TGTX

Tg Therapeutics Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 9/10
  • Value↓ 1/10
Tg Therapeutics sales and earnings growth
TGTX Growth
Great
  • Revenue Y/Y↑ 87.32%
  • EPS Y/Y↑ 1837.50%
  • FCF Y/Y↑ 38.40%
Tg Therapeutics gross and profit margin trends
TGTX Profitability
Great
  • Gross margin ↑ 83.70%
  • EPS margin↑ 72.60%
  • ROIC 5Y↑ -10.63%
Tg Therapeutics net debt vs free cash flow
TGTX Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↑ 6.9
  • Interest coverage↑ 5.0

Tg Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗